Genprex
GNPX
29 hedge funds and large institutions have $15.9M invested in Genprex in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 5 increasing their positions, reducing their positions, and 1 closing their positions.
2,000% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 1
667% more capital invested
Capital invested by funds: $2.07M → $15.9M (+$13.8M)
222% more funds holding
Funds holding: 9 → 29 (+20)
0% more ownership
Funds ownership: 0% → 0% (+0%)
80% less call options, than puts
Call options by funds: $171K | Put options by funds: $847K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.13M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.22M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$978K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$611K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$611K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$105K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$22K |
GNPX Hedge Fund Activity: Q2 2020 in Review
29 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2020, worth a combined $15.9M — up 667% from $2.07M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new GNPX positions and 1 closed out — a net gain of 20 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $5.13M. The largest seller was Millennium Management, exiting entirely with an estimated $105K sold.
- 29 institutional investors held Genprex (GNPX) as of Q2 2020, up from 9 in Q1 2020.
- Funds reported $15.9M of Genprex stock for Q2 2020, up 667% quarter-over-quarter.
- 21 funds opened new Genprex positions in Q2 2020 and 1 closed out, a net change of +20 holders.
- The largest Genprex buyer in Q2 2020 was BlackRock, an estimated $5.13M added.
- The largest Genprex seller in Q2 2020 was Millennium Management, an estimated $105K sold.
Based on aggregated 13F filings for Q2 2020.